Regenerative Therapy Using Blood-Derived Stem Cells (eBook)

Dr. David S. Allan is a clinician scientist at the Ottawa Hospital Research Institute, affiliated with the Blood & Marrow Transplant Program at the University of Ottawa. His research interests focus of fundamental aspects of vascular progenitor biology and on translational studies in the repair of organ toxicity in patients undergoing hematopoietic stem cell transplantation.  Dr. Dirk Strunk is a clinician scientist with the Hematopoietic Stem Cell Transplantation Program and Head of Stem Cell Research at the Medical University of Graz in Austria. His research team develops novel transplantation strategies using mesenchymal stromal cells and endothelial progenitors and has developed animal protein-free methods of cell expansion that facilitate translational studies in humans.

Undertaking Regenerative Medicine Studies with Blood Stem Cells.- Defining Endothelial Progenitor Cells.- Blood-Derived ALDHhi Cells in Tissue Repair.- Blood-Derived Mesenchymal Stem Cells and Tissue Repair.- Animal Protein-Free Expansion of Human Mesenchymal Stem / Progenitor Cells.- Defining Hierarchies of Unrestricted Somatic Stem Cells and Mesenchymal Stem Cells in Cord Blood.- Induced Pluripotent Stem Cells from Blood.- Endothelial Progenitors and Repair of Cardiovascular Disease.- Bone Marrow-Derived Cells as Treatment Vehicles in the Central Nervous System.- Regenerative Potential of Blood Stem Cell Products Used in Hematopoietic Stem Cell Transplantation.- Concepts to Facilitate Umbilical Cord Blood Transplantation.- Cord Blood Banking for Regenerative Therapy.- Regulatory Questions in the Development of Blood Stem Cell Products for Regenerative Therapy.- Cell Therapy Regulations from a European Perspective.- EBMT Registry of Non-Hematopoietic Stem Cells and Regenerative Therapy (Cellular and Engineered Tissue Therapies in Europe).